Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: Successful treatment for new and rare entity | Zendy

Jerbi Mouna | Zendy; El Fatmi Rym | Zendy; Gaied Hanene | Zendy; Belloumi Dorra | Zendy; Torjemane Lamia | Zendy; Aoudia Raja | Zendy; Goucha Rim | Zendy; Abdallah Taieb Ben | Zendy; Othman Tarek Ben | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: Successful treatment for new and rare entity

Author(s) -

Jerbi Mouna,

El Fatmi Rym,

Gaied Hanene,

Belloumi Dorra,

Torjemane Lamia,

Aoudia Raja,

Goucha Rim,

Abdallah Taieb Ben,

Othman Tarek Ben

Publication year - 2021

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.3439

Subject(s) - medicine , cyclophosphamide , glomerulonephritis , bortezomib , autologous stem cell transplantation , rapidly progressive glomerulonephritis , monoclonal antibody , monoclonal , dexamethasone , transplantation , antibody , treatment modality , immunology , pathology , multiple myeloma , chemotherapy , kidney

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits is a new disorder with undefined treatment modalities. We propose cyclophosphamide‐bortezomib‐dexamethasone and autologous stem cell transplantation as a therapeutic protocol.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research